We performed a randomized, double-blind, placebo-controlled trial in 555 patients with unstable angina who were hospitalized in coronary care units. Patients received one of four possible treatment regimens: aspirin (325 mg four times daily), sulfinpyrazone (200 mg four times daily), both, or neither. They were entered into the trial within eight days of hospitalization and were treated and followed for up to two years (mean, 18 months). The incidence of cardiac death and nonfatal myocardial infarction, considered together, was 8.6 per cent in the groups given aspirin and 17.0 per cent in the other groups, representing a risk reduction with aspirin of 51 per cent (P = 0.008). The corresponding figures for either cardiac death alone or death from any cause were 3.0 per cent in the groups given aspirin and 11.7 per cent in the other groups, representing a risk reduction of 71 per cent (P = 0.004). Analysis by intention to treat yielded smaller risk reductions with aspirin of 30 per cent (P = 0.072), 56 per cent (P = 0.009), and 43 per cent (P = 0.035) for the outcomes of cardiac death or nonfatal acute myocardial infarction, cardiac death alone, and all deaths, respectively. There was no observed benefit of sulfinpyrazone for any outcome event, and there was no evidence of an interaction between sulfinpyrazone and aspirin. Considered together with the results of a previous clinical trial, these findings provide strong evidence for a beneficial effect of aspirin in patients with unstable angina.
This article has been cited by other articles:
Kumar, A., Cannon, C. P.
(2009). Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clin Proc.
84: 917-938
[Abstract][Full Text]
Jolly, S. S., Pogue, J., Haladyn, K., Peters, R. J.G., Fox, K. A.A., Avezum, A., Gersh, B. J., Rupprecht, H. J., Yusuf, S., Mehta, S. R.
(2009). Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. Eur Heart J
30: 900-907
[Abstract][Full Text]
ALEXANDER, J. H.
(2009). The current state of antiplatelet therapy in acute coronary syndromes: The data and the real world. Cleveland Clinic Journal of Medicine
76: S16-S23
[Abstract][Full Text]
Konstam, M. A.
(2009). Antithrombotic Therapy in Heart Failure: WATCHful Wondering. Circulation
119: 1559-1561
[Full Text]
Hollenberg, S. M.
(2009). Acute Coronary Syndromes. ACCP Crit Care Med Brd Rev
20: 129-144
[Full Text]
Ang, L., Mahmud, E.
(2008). Monitoring oral antiplatelet therapy: is it justified?. Ther Adv Cardiovasc Dis
2: 485-496
[Abstract]
Woollard, M., Elwood, P. C, Morgan, G.
(2008). Life saving early and immediate aspirin: too little too late. Postgrad. Med. J.
84: 337-338
[Full Text]
Patrono, C., Baigent, C., Hirsh, J., Roth, G.
(2008). Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 199S-233S
[Abstract][Full Text]
Harrington, R. A., Becker, R. C., Cannon, C. P., Gutterman, D., Lincoff, A. M., Popma, J. J., Steg, G., Guyatt, G. H., Goodman, S. G.
(2008). Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 670S-707S
[Abstract][Full Text]
Patrono, C., Rocca, B.
(2008). Aspirin: Promise and Resistance in the New Millennium. Arterioscler. Thromb. Vasc. Bio.
28: s25-s32
[Abstract][Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: 652-726
[Full Text]
Meadows, T. A., Bhatt, D. L.
(2007). Clinical Aspects of Platelet Inhibitors and Thrombus Formation. Circ. Res.
100: 1261-1275
[Abstract][Full Text]
Mehta, S. R.
(2006). Clopidogrel in non-ST-segment elevation acute coronary syndromes. Eur Heart J Suppl
8: G25-G30
[Abstract][Full Text]
Masoudi, F. A., Wolfe, P., Havranek, E. P., Rathore, S. S., Foody, J. M., Krumholz, H. M.
(2005). Aspirin Use in Older Patients With Heart Failure and Coronary Artery Disease: National Prescription Patterns and Relationship With Outcomes. J Am Coll Cardiol
46: 955-962
[Abstract][Full Text]
Saseen, J. J.
(2005). ASHP Therapeutic Position Statement on the Daily Use of Aspirin for Preventing Cardiovascular Events. Am J Health Syst Pharm
62: 1398-1405
[Full Text]
Gluckman, T. J., Sachdev, M., Schulman, S. P., Blumenthal, R. S.
(2005). A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA
293: 349-357
[Abstract][Full Text]
Tran, H., Anand, S. S.
(2004). Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease. JAMA
292: 1867-1874
[Abstract][Full Text]
Wiggins, B. S., Spinler, S.
(2004). Antiplatelet and Antithrombin Therapy for Early Management of Acute Coronary Syndromes. Journal of Pharmacy Practice
17: 347-369
[Abstract]
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., Roth, G.
(2004). Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 234S-264S
[Abstract][Full Text]
Harrington, R. A., Becker, R. C., Ezekowitz, M., Meade, T. W., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H.
(2004). Antithrombotic Therapy for Coronary Artery Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 513S-548S
[Abstract][Full Text]
Quinn, M. J., Aronow, H. D., Califf, R. M., Bhatt, D. L., Sapp, S., Kleiman, N. S., Harrington, R. A., Kong, D. F., Kandzari, D. E., Topol, E. J.
(2004). Aspirin dose and six-month outcome after an acute coronary syndrome. J Am Coll Cardiol
43: 972-978
[Abstract][Full Text]
Behan, M W H, Storey, R F
(2004). Antiplatelet therapy in cardiovascular disease. Postgrad. Med. J.
80: 155-164
[Abstract][Full Text]
Peters, R. J.G., Mehta, S. R., Fox, K. A.A., Zhao, F., Lewis, B. S., Kopecky, S. L., Diaz, R., Commerford, P. J., Valentin, V., Yusuf, S., for the Clopidogrel in Unstable angina to prevent,
(2003). Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study. Circulation
108: 1682-1687
[Abstract][Full Text]
Prasad, A., Mathew, V., Holmes, D. R Jr., Gersh, B. J
(2003). Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur Heart J
24: 1544-1553
[Abstract][Full Text]
McAlister, F. A., Straus, S. E., Sackett, D. L., Altman, D. G.
(2003). Analysis and Reporting of Factorial Trials: A Systematic Review. JAMA
289: 2545-2553
[Abstract][Full Text]
Hersi, A., Fu, Y., Wong, B., Mahaffey, K.W., Harrington, R.A., Califf, R.M., Van de Werf, F., Armstrong, P.W., for the PARAGON-B Investigators,
(2003). Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?. Eur Heart J
24: 522-531
[Abstract][Full Text]
Mehta, S. R., Yusuf, S.
(2003). Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol
41: 79S-88S
[Abstract][Full Text]
Steg, P G, Iung, B, Feldman, L J, Cokkinos, D, Deckers, J, Fox, K A A, Keil, U, Maggioni, A P
(2002). Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart
88: 20-24
[Abstract][Full Text]
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., Kleiman, N. S., Theroux, P., Topol, E. J.
(2001). Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non-ST-Segment-Elevation Acute Coronary Syndromes. Circulation
104: 2767-2771
[Abstract][Full Text]
Vila, J. M, Martinez-Leon, J. B, Medina, P., Segarra, G., Ballester, R. M, Otero, E., Lluch, S.
(2001). U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade. Cardiovasc Res
52: 462-467
[Abstract][Full Text]
Woollard, M, Smith, A, Elwood, P
(2001). Pre-hospital aspirin for suspected myocardial infarction and acute coronary syndromes: A headache for paramedics?. Emerg. Med. J.
18: 478-481
[Abstract][Full Text]
Fihn, S. D., Williams, S. V., Daley, J., Gibbons, R. J.
(2001). Guidelines for the Management of Patients with Chronic Stable Angina: Treatment. ANN INTERN MED
135: 616-632
[Abstract][Full Text]
Kher, A., Samama, M.M.
(2001). Low-Molecular-Weight Heparins: Weeks or Months Instead of Days of Treatment. CLIN APPL THROMB HEMOST
7: 314-320
[Abstract]
Gum, P. A., Thamilarasan, M., Watanabe, J., Blackstone, E. H., Lauer, M. S.
(2001). Aspirin Use and All-Cause Mortality Among Patients Being Evaluated for Known or Suspected Coronary Artery Disease: A Propensity Analysis. JAMA
286: 1187-1194
[Abstract][Full Text]
Cruz-Fernandez, J.M.
(2001). Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors. Eur Heart J Suppl
3: I23-I30
[Abstract]
Turpie, A. G. G., Antman, E. M.
(2001). Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes. Arch Intern Med
161: 1484-1490
[Abstract][Full Text]
Levine, G. N., Ali, M. N., Schafer, A. I.
(2001). Antithrombotic Therapy in Patients With Acute Coronary Syndromes. Arch Intern Med
161: 937-948
[Abstract][Full Text]
Rauch, U., Osende, J. I., Fuster, V., Badimon, J. J., Fayad, Z., Chesebro, J. H.
(2001). Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences. ANN INTERN MED
134: 224-238
[Abstract][Full Text]
Patrono, C., Coller, B., Dalen, J. E., FitzGerald, G. A., Fuster, V., Gent, M., Hirsh, J., Roth, G.
(2001). Platelet-Active Drugs : The Relationships Among Dose, Effectiveness, and Side Effects. Chest
119
: 39S-63S
[Full Text]
Cairns, J. A., Theroux, P., Lewis, H. D. Jr., Ezekowitz, M., Meade, T. W.
(2001). Antithrombotic Agents in Coronary Artery Disease. Chest
119
: 228S-252S
[Full Text]
Manhapra, A., Borzak, S.
(2000). Regular review: Treatment possibilities for unstable angina. BMJ
321: 1269-1275
[Full Text]
Ageno, W., Turpie, A. G.
(2000). Therapy of unstable angina with the low molecular weight heparins. Vasc Med
5: 217-223
[Abstract]
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., Pepine, C. J., Schaeffer, J. W., Smith, E. E. III, Steward, D. E., Theroux, P., Gibbons, R. J., Alpert, J. S., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr
(2000). ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol
36: 970-1062
[Full Text]
Pratico, D., Cheng, Y., FitzGerald, G. A.
(2000). TP or Not TP: Primary Mediators in a Close Runoff?. Arterioscler. Thromb. Vasc. Bio.
20: 1695-1698
[Full Text]
Abrahamsson, P, Rosengren, A, Dellborg, M
(2000). Improved long-term prognosis for patients with unstable coronary syndromes 1988-1995. Eur Heart J
21: 533-539
[Abstract]
Lincoff, A. M., Califf, R. M., Topol, E. J.
(2000). Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol
35: 1103-1115
[Abstract][Full Text]
Awtry, E. H., Loscalzo, J.
(2000). Aspirin. Circulation
101: 1206-1218
[Full Text]
Brodison, A., Katira, R., More, R. S, Chauhan, A.
(2000). Current practice: Antiplatelet use in interventional cardiology. Postgrad. Med. J.
76: 70-79
[Abstract][Full Text]
Yeghiazarians, Y., Braunstein, J. B., Askari, A., Stone, P. H.
(2000). Unstable Angina Pectoris. NEJM
342: 101-114
[Full Text]
Oldgren, J., Linder, R., Grip, L., Siegbahn, A., Wallentin, L.
(1999). Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease. Eur Heart J
20: 1657-1666
[Abstract]
Klein, M., Keith, P.R., Dauben, H.-P., Schulte, H.D., Beckmann, H., Mayer, G., Elert, O., Gams, E.
(1999). Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin. Eur. J. Cardiothorac. Surg.
14: 360-366
[Abstract][Full Text]
Zed, P. J., Tisdale, J. E., Borzak, S.
(1999). Low-Molecular-Weight Heparins in the Management of Acute Coronary Syndromes. Arch Intern Med
159: 1849-1857
[Abstract][Full Text]
Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O'Rourke, R. A., Schafer, W. P., Williams, S. V., Ritchie, J. L., Gibbons, R. J., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Russell, R. O., Ryan, T. J., Smith, S. C. Jr
(1999). ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol
33: 2092-2197
[Full Text]
KENNON, S, TIMMIS, A
(1999). Management of unstable angina: what role intervention, ask the RITA-3 trialists?. Heart
81: 565-566
[Full Text]
van der Loo, B., Martin, J. F.
(1999). A Role for Changes in Platelet Production in the Cause of Acute Coronary Syndromes. Arterioscler. Thromb. Vasc. Bio.
19: 672-679
[Abstract][Full Text]
Alexander, K. P., Peterson, E. D., Granger, C. B., Casas, A. C., Van de Werf, F., Armstrong, P. W., Guerci, A., Topol, E. J., Califf, R. M., for the GUSTO-IIB Investigators,
(1998). Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. J Am Coll Cardiol
32: 2023-2030
[Abstract][Full Text]
Ritchie, M. E.
(1998). Nuclear Factor-{kappa}B Is Selectively and Markedly Activated in Humans With Unstable Angina Pectoris. Circulation
98: 1707-1713
[Abstract][Full Text]
Every, N. R., Cannon, C. P., Granger, C., Moliterno, D. J., Aguirre, F. V., Talley, J. D., Booth, J., Sapp, S., Ferguson, J. J., for the GUARANTEE investigators,
(1998). Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE registry. J Am Coll Cardiol
32: 387-392
[Abstract][Full Text]
(1998). International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina. Circulation
97: 2386-2395
[Abstract][Full Text]
Giugliano, R. P., Camargo, C. A. Jr, Lloyd-Jones, D. M., Zagrodsky, J. D., Alexis, J. D., Eagle, K. A., Fuster, V., O'Donnell, C. J.
(1998). Elderly Patients Receive Less Aggressive Medical and Invasive Management of Unstable Angina: Potential Impact of Practice Guidelines. Arch Intern Med
158: 1113-1120
[Abstract][Full Text]
The Platelet Receptor Inhibition in Ischemic Syndr,
(1998). A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina. NEJM
338: 1498-1505
[Abstract][Full Text]
Eccles, M., Freemantle, N., Mason, J., Group, t. N. o. E. A. G. D.
(1998). North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ
316: 1303-1309
[Full Text]
Theroux, P., Fuster, V.
(1998). Acute Coronary Syndromes : Unstable Angina and Non–Q-Wave Myocardial Infarction. Circulation
97: 1195-1206
[Full Text]
Lehmann, K. G., van Suylen, R. J., Stibbe, J., Slager, C. J., Oomen, J. A., Maas, A., di Mario, C., deFeyter, P., Serruys, P. W.
(1997). Composition of Human Thrombus Assessed by Quantitative Colorimetric Angioscopic Analysis. Circulation
96: 3030-3041
[Abstract][Full Text]
Owa, M., Origasa, H., Saito, M., Owa, M.
(1997). Predictive Validity of the Braunwald Classification of Unstable Angina for Angiographic Findings, Short-Term Prognoses, and Treatment Selection. ANGIOLOGY
48: 663-671
[Abstract]
Kaplan, S., Kaplan, A., Marcoe, K. F., Hammond, W. P., Fisher, L. D., Sauvage, L. R.
(1997). Citric Acid Enhances the Antithrombotic Effect of Aspirin in Many Aspirin-Resistant Subjects. CLIN APPL THROMB HEMOST
3: 54-57
[Abstract]
Oler, A., Whooley, M. A., Oler, J., Grady, D.
(1996). Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients With Unstable Angina: A Meta-analysis. JAMA
276: 811-815
[Abstract]
Eisenberg, M. J., Topol, E. J.
(1996). Prehospital Administration of Aspirin in Patients With Unstable Angina and Acute Myocardial Infarction. Arch Intern Med
156: 1506-1510
[Abstract]
Ambrose, J. A., Weinrauch, M.
(1996). Thrombosis in Ischemic Heart Disease. Arch Intern Med
156: 1382-1394
[Abstract]
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., Goldschmidt-Clermont, P. J.
(1996). A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis. NEJM
334: 1090-1094
[Abstract][Full Text]
Savi, P., Heilmann, E., Nurden, P., Laplace, M.-C., Bihour, C., Kieffer, G., Nurden, A. T., Herbert, J.-M.
(1996). Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets. CLIN APPL THROMB HEMOST
2: 35-42
[Abstract]
Savage, M. P., Goldberg, S., Bove, A. A., Deutsch, E., Vetrovec, G., Macdonald, R. G., Bass, T., Margolis, J. R., Whitworth, H. B., Taussig, A., Hirshfeld, J. W., Cowley, M., Hill, J. A., Marks, R. G., Fischman, D. L., Handberg, E., Herrmann, H., Pepine, C. J.
(1995). Effect of Thromboxane A2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty : Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation
92: 3194-3200
[Abstract][Full Text]
Wang, J.-s., Jen, C. J., Chen, H.-i.
(1995). Effects of Exercise Training and Deconditioning on Platelet Function in Men. Arterioscler. Thromb. Vasc. Bio.
15: 1668-1674
[Abstract][Full Text]
Fuchs, J., Cannon, C. P.
(1995). Hirulog in the Treatment of Unstable Angina : Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 Trial. Circulation
92: 727-733
[Abstract][Full Text]
Weil, J., Colin-Jones, D., Langman, M., Lawson, D., Logan, R., Murphy, M., Rawlins, M., Vessey, M., Wainwright, P.
(1995). Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ
310: 827-830
[Abstract][Full Text]
Morris, C. R., Scheib, J. S.
(1994). Fatal Myocardial Infarction Resulting From Coronary Arteritis in a Patient With Polymyalgia Rheumatica and Biopsy-Proved Temporal Arteritis: A Case Report and Review of the Literature. Arch Intern Med
154: 1158-1160
[Abstract]
Patrono, C.
(1994). Aspirin as an Antiplatelet Drug. NEJM
330: 1287-1294
[Full Text]
Woods, S. E.
(1994). Primary Prevention of Coronary Heart Disease in Women: Should Asymptomatic Women 50 Years of Age Take Aspirin Regularly?. Arch Fam Med
3: 361-364
[Abstract]
Murkin, J. M., Lux, J., Shannon, N. A., Guiraudon, G. M., Menkis, A. H., McKenzie, F. N., Novick, R. J.
(1994). Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J. Thorac. Cardiovasc. Surg.
107: 554-561
[Abstract][Full Text]
Antiplatelet Trialists,
(1994). Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ
308: 81-106
[Abstract][Full Text]
Fletcher, J. R.
(1993). Eicosanoids: Critical Agents in the Physiological Process and Cellular Injury. Arch Surg
128: 1192-1196
[Abstract]
Sivenius, J., Riekkinen, P. J., Lowenthal, A., Smets, P., Laakso, M.
(1993). Antiplatelet Therapy Is Effective in Primary Prevention of Myocardial Infarction in Patients With a Previous Cerebrovascular Ischemic Event. Arch Neurol
50: 710-713
[Abstract]
Shebuski, R. J.
(1993). Interruption of Thrombosis and Hemostasis by Anti-Platelet Agents. Toxicol Pathol
21: 180-189
[Abstract]
Rothrock, J. F., Hart, R. G.
(1991). Antithrombotic Therapy in Cerebrovascular Disease. ANN INTERN MED
115: 885-895
[Abstract]
The Asymptomatic Cervical Bruit Study Group,
(1991). Natural History and Effectiveness of Aspirin in Asymptomatic Patients With Cervical Bruits. Arch Neurol
48: 683-686
[Abstract]
Dalen, J. E.
(1991). An Apple a Day or an Aspirin a Day?. Arch Intern Med
151: 1066-1069
[Abstract]
Ridker, P. M., Manson, J. E., Gaziano, J. M., Buring, J. E., Hennekens, C. H.
(1991). Low-Dose Aspirin Therapy for Chronic Stable Angina: A Randomized, Placebo-Controlled Clinical Trial. ANN INTERN MED
114: 835-839
[Abstract]
Pepine, C. J.
(1991). Circadian Variations in Myocardial Ischemia: Implications for Management. JAMA
265: 386-390
[Abstract]
Bashein, G., Nessly, M. L., Rice, A. L., Counts, R. B., Misbach, G. A.
(1991). Preoperative Aspirin Therapy and Reoperation for Bleeding After Coronary Artery Bypass Surgery. Arch Intern Med
151: 89-93
[Abstract]
Marmur, J. D., Freeman, M. R., Langer, A., Armstrong, P. W.
(1990). Prognosis in Medically Stabilized Unstable Angina: Early Holter ST-Segment Monitoring Compared with Predischarge Exercise Thallium Tomography. ANN INTERN MED
113: 575-579
[Abstract]
Detsky, A. S.
(1989). Are Clinical Trials a Cost-effective Investment?. JAMA
262: 1795-1800
[Abstract]
Lee, T. H., Weisberg, M. C., Brand, D. A., Rouan, G. W., Goldman, L.
(1989). Candidates for Thrombolysis among Emergency Room Patients with Acute Chest Pain: Potential True- and False-Positive Rates. ANN INTERN MED
110: 957-962
[Abstract]
Yusuf, S., Wittes, J., Friedman, L.
(1988). Overview of Results of Randomized Clinical Trials in Heart Disease: II. Unstable Angina, Heart Failure, Primary Prevention With Aspirin, and Risk Factor Modification. JAMA
260: 2259-2263
[Abstract]
Johnson, E., Ports, T.
(1988). Unstable Angina Pectoris: An Interventional Approach to Management. J Intensive Care Med
3: 202-214
[Abstract]
